ResMed targets 59-60% gross margins and expanded global reach for AirSense 11

CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and ...
Nasdaq

ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy ...

SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) launched today its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, ...
Healio

FDA grants de novo clearance to bacterial reduction device for CPAP masks, hoses

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo clearance to SoClean 3+, an over-the-counter bacterial reduction device for certain ...
FierceBiotech

FDA clears Resmed AI for personalizing CPAP settings

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has ...